학술논문
Safety and Sustained Efficacy of the Farnesoid X Receptor (FXR) Agonist Cilofexor Over a 96-Week Open-label Extension in Patients With PSC
Document Type
Article
Author
Source
In Clinical Gastroenterology and Hepatology June 2023 21(6):1552-1560
Subject
Language
ISSN
1542-3565